In a landmark reversal, the American Medical Association urged the federal government to review marijuana’s schedule classification from a Schedule I drug, meaning it has no medicinal value, so that further ‘development of cannabinoid-based medicines’ can be achieved.
Since 1970, the only government-based research in the country was in the University of Mississippi, where medical marijuana has been grown and distributed, but with little research and control. With the AMA requesting marijuana be reclassified so that medicine can further the advancements of medical marijuana research and help determine the efficacy of medical cannabis for all it’s potential.
